Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background: Extensive-stage small cell lung cancer (ES-SCLC) is highly aggressive with dismal prognosis, and platinum monochemotherapy offers modest long-term survival. Multiple first-line regimens integrating immunotherapy, anti-angiogenic agents and chemotherapy have been approved, yet direct head-to-head comparisons are scarce, and the optimal induction plus maintenance strategy remains undefined.
aNursing Administration Department, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China bSchool of Nursing, The Hong Kong Polytechnic University, Hong Kong, China cSchool of Nursing, The Guangzhou Medical University, Guangzhou, Guangdong Province, China dPulmonary and Critical Care Medicine Department, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China eTraditional Chinese Medicine Department, The...
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
